News

News
Partner news

PhaseBio Launches Clinical Program to Test Lead Product for Sustained 24/7 Glycemic Control in Type 2 Diabetics

Read full story
Partner news

Syntaxin Raises £18 Million in New Financing

Read full story
Partner news

23andMe Raises More Than $22 Million in Series C Financing

Read full story
Partner news

Biolex and Merial Broaden Collaboration

Read full story
Partner news

NeuroPace Submits PMA Application for FDA Approval of Novel Investigational Device for Epilepsy

Read full story
Partner news

Metabolex Enters into Type 2 Diabetes Development and License Agreement

Read full story
Partner news

Aquinox Pharmaceuticals Completes US $25 million Series B financing

Read full story
Partner news

Breathe Technologies Secures $23 Million in Series C Financing

Read full story
Partner news

Astute Medical Announces $26.5 Million Series B Financing

Read full story
Partner news

Molecular Partners Progresses DARPin into First-in-Humans Clinical Studies

Read full story
Partner news

Celladon Corp. Announces that MYDICAR® Meets Primary Endpoint in Phase 2 Trial for Treatment of Advanced Heart Failure

Read full story
Partner news

Biolex Announces Presentation at EASL of Interim Results from Select-2 Phase 2b Trial of Locteron® in Chronic Hepatitis C

Read full story
Partner news

Encouraging Data from Three Astex Collaborative Programmes to Be Presented at the 101st American Association for Cancer Research (AACR) Annual Meeting 2010

Read full story
Partner news

iScience Interventional, Inc Enters into a Collaborative Supply Agreement with Centocor Research and Development, Inc on a Minimally-Invasive Approach to Deliver Cell Therapies

Read full story
Partner news

Study Demonstrates People Living with Type 2 Diabetes and Obesity Can Be Successfully Treated with GI Dynamics' EndoBarrier™ Gastrointestinal Liner for 12 Months

Read full story